Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties
- 1 February 1988
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 41 (3) , 245-254
- https://doi.org/10.1016/0378-5173(88)90201-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Preparation and pharmacological evaluation of captopril sustained-release dosage forms using oily semisolid matrixInternational Journal of Pharmaceutics, 1988
- Evaluation of sustained-release capsules of molsidomine (SIN-10) in dogs and monkeys.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Captopril kineticsClinical Pharmacology & Therapeutics, 1982
- Effect of Food on the Bioavailability of Captopril in Healthy SubjectsThe Journal of Clinical Pharmacology, 1982
- Determination of captopril in blood and urine by high-performance liquid chromatography.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981
- Disposition of captopril in normal subjectsClinical Pharmacology & Therapeutics, 1980
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Determination of sulfhydryl groups with 2,2′- or 4,4′-dithiodipyridineArchives of Biochemistry and Biophysics, 1967
- Factors Affecting the Absorption of Riboflavin in ManJournal of Pharmaceutical Sciences, 1966
- FACTORS INFLUENCING THE INTESTINAL ABSORPTION OF CERTAIN MONOQUATERNARY ANTICHOLINERGIC COMPOUNDS WITH SPECIAL REFERENCE TO BENZOMETHAMINE [N-DIETHYLAMINOETHYL-N'-METHYL-BENZILAMIDE METHOBROMIDE (MC-3199)]1955